Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome

被引:202
作者
Boultwood, J
Fidler, C
Strickson, AJ
Watkins, F
Gama, S
Kearney, L
Tosi, S
Kasprzyk, A
Cheng, JF
Jaju, RJ
Wainscoat, JS
机构
[1] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Leukaemia Res Fund Mol Haematol Unit, Oxford OX3 9DU, England
[2] Univ Oxford, John Radcliffe Hosp, MRC, Mol Haematol Unit,Inst Mol Med, Oxford OX3 9DU, England
[3] European Bioinformat Inst, Cambridge, England
[4] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA
关键词
D O I
10.1182/blood.V99.12.4638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 5q- syndrome is the most distinct of the myelodysplastic syndromes, and the molecular basis for this disorder remains unknown. We describe the narrowing of the common deleted region (CDR) of the 5q- syndrome to the approximately 1.5-megabases interval at 5q32 flanked by D5S413 and the GLRA1 gene. The Ensembl gene prediction program has been used for the complete genomic annotation of the CDR. The CDR is gene rich and contains 24 known genes and 16 novel (predicted) genes. Of 40 genes in the CDR, 33 are expressed in CD34(+) cells and, therefore, represent candidate genes since they are expressed within the hematopoietic stem/progenitor cell compartment. A number of the genes assigned to the CDR represent good candidates for the 5q- syndrome, including MEGF1, G3BP, and several of the novel gene predictions. These data now afford a comprehensive mutational/expression analysis of all candidate genes assigned to the CDR. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:4638 / 4641
页数:4
相关论文
共 22 条
  • [1] [Anonymous], 1996, Nat Genet, V14, P86
  • [2] BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
  • [3] MOLECULAR MAPPING OF UNCHARACTERISTICALLY SMALL 5Q DELETIONS IN 2 PATIENTS WITH THE 5Q- SYNDROME - DELINEATION OF THE CRITICAL REGION ON 5Q AND IDENTIFICATION OF A 5Q- BREAKPOINT
    BOULTWOOD, J
    FIDLER, C
    LEWIS, S
    KELLY, S
    SHERIDAN, H
    LITTLEWOOD, TJ
    BUCKLE, VJ
    WAINSCOAT, JS
    [J]. GENOMICS, 1994, 19 (03) : 425 - 432
  • [4] BOULTWOOD J, 1994, BLOOD, V84, P3253
  • [5] Novel genes mapping to the critical region of the 5q-syndrome
    Boultwood, J
    Fidler, C
    Soularue, P
    Strickson, AJ
    Kostrzewa, M
    Jaju, RJ
    Cotter, FE
    Fairweather, N
    Monaco, AP
    Muller, U
    Lovett, M
    Jabs, EW
    Auffray, C
    Wainscoat, JS
    [J]. GENOMICS, 1997, 45 (01) : 88 - 96
  • [6] The human POP2 gene:: Identification, sequencing, and mapping to the critical region of the 5q- syndrome
    Fidler, C
    Wainscoat, JS
    Boultwood, J
    [J]. GENOMICS, 1999, 56 (01) : 134 - 136
  • [7] Fidler C, 2001, GENE SCREEN, V1, P165
  • [8] ALPHA-SUBUNIT VARIANTS OF THE HUMAN GLYCINE RECEPTOR - PRIMARY STRUCTURES, FUNCTIONAL EXPRESSION AND CHROMOSOMAL LOCALIZATION OF THE CORRESPONDING GENES
    GRENNINGLOH, G
    SCHMIEDEN, V
    SCHOFIELD, PR
    SEEBURG, PH
    SIDDIQUE, T
    MOHANDAS, TK
    BECKER, CM
    BETZ, H
    [J]. EMBO JOURNAL, 1990, 9 (03) : 771 - 776
  • [9] HEANEY JL, 1993, NEW ENGL J MED, V340, P1649
  • [10] Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31
    Horrigan, SK
    Arbieva, ZH
    Xie, HY
    Kravarusic, J
    Fulton, NC
    Naik, H
    Le, TT
    Westbrook, CA
    [J]. BLOOD, 2000, 95 (07) : 2372 - 2377